UKRMP Regenerative Medicine 2023 – Registration Launch

By | Acellular / smart materials – 3D architecture, Engineered cell environment, Event, Latest, Pluripotent stem cells and engineered cells

The UK Regenerative Medicine Platform (UKRMP) is pleased to present an exciting programme of exceptional research in the field of Regenerative Medicine. Aimed at bringing together an international audience of researchers with a desire to hear about research, tools and techniques to progress cutting edge science from bench to bedside. Hear from experts in the field, and join us to build your network, as we celebrate 10 years of UK Regenerative Medicine translational research.

Meeting Aims:
The UK Regenerative Medicine Platform (UKRMP) was established over 10 years ago to try to address the Key Translational Challenges of Regenerative Medicine. UKRMP Regenerative Medicine 2023, aims to showcase the progress of UK translational regenerative medicine research and hopes to build on the success of UKRMP outputs, industrial collaborations and clinical application.

Who Should Attend?
Anyone with an interest in Regenerative Medicine, tools and techniques for cutting edge science and progress from bench to bedside.

Download Draft Programme

Confirmed Speakers:

  • Rawiya Al Hosni, Postdoctoral Researcher, University of Cambridge, UK
  • Ivana Barbaric, Professor, University of Sheffield, UK
  • Roger Barker, Professor, University of Cambridge, UK
  • Jacqueline Barry, Chief Clinical Officer, Cell and Gene Therapy Catapult, UK
  • Catherine Beltran-Rendon, Postdoctoral Researcher, Loughborough University, UK
  • Robin Buckle, Chief Science Officer, Medical Research Council, UK
  • Neil Carragher, Professor, University of Edinburgh, UK
  • Jonathan Dawson, Associate Professor, University of Southampton, UK
  • Charlotte Durkin, Head of Multimodal and Multiscale Biology, Medical Research Council, UK
  • Alicia El Haj, Professor, University of Birmingham, UK
  • Elaine Emmerson, RCUK/UKRI Innovation Fellow & Chancellor’s Fellow, University of Edinburgh, UK
  • Stuart Forbes, Professor, University of Edinburgh, UK
  • Victoria Gadd, Postdoctoral Research Fellow, University of Edinburgh, UK
  • Cedric Ghevaert, Professor, University of Cambridge, UK
  • David Hay, Professor, University of Edinburgh, UK/Founder, Chairman and CEO, Stimuliver, Denmark
  • Zoe Hewitt, Co-Founder and CEO, Regenerative Cell Therapy Consulting Ltd, UK
  • Yuki Ishii, Postdoctoral Researcher, University College London, UK
  • Agnieszka Janeczek, Founder and CEO, Renovos, UK
  • Joanne Jones, Associate Professor, University of Cambridge, UK
  • Janos Kanczler, Lecturer, University of Southampton, UK
  • Owen Laing, PhD Student, University of Sheffield, UK
  • Hannah Levis, Senior Lecturer, University of Liverpool, UK
  • Andrew McCaskie, Professor, University of Cambridge, UK
  • Florian Merkle, Principle Investigator, University of Cambridge, UK
  • Pierre-Alexis Mouthuy, Associate Professor, University of Oxford, UK
  • Marko Nikolic, MRC Clinician Scientist Fellow, University College London, UK
  • Malin Palmer, Professor, Lund University, Sweden
  • Rachael Pearson, Professor, King’s College London, UK
  • Graziella Pellegrini, Professor, University of Modena and Reggio Emilia, Italy
  • Jelle Penders, Co-founder and CEO, SPARTA Biodiscovery Ltd, UK
  • Felicity Rose, Professor, University of Nottingham, UK
  • Kourosh Saeb-Parsy, Professor, University of Cambridge, UK
  • Manuel Salmeron-Sanchez, Professor, University of Glasgow, UK
  • Stefan Schoenfelder, Career Progression Fellow, Babraham Institute, UK
  • Hazel Screen, Professor, Queen Mary University of London, UK
  • Molly Stevens, Professor, University of Oxford and Imperial College London, UK
  • Sarah Waters, Professor, University of Oxford, UK
  • Lisa White, Associate Professor, University of Nottingham, UK
  • Jonathan Wojciechowski, Postdoctoral Research Associate, Imperial College London, UK

Key Information and Dates

Registration Closes: Midnight Monday 30th October 2023

Printed Poster Deadline: Wednesday 1 November 2023

Register as a Delegate
Submit a Poster Abstract

Event Sponsors

For details on our remaining sponsorship opportunities please contact us

Principal Sponsors

Premium Exhibitors

Exhibitors

Supporting Sponsors

Regenerative Cell Therapy Consulting

UKRMP Regenerative Medicine 2023 – Save the Dates 8-10 Nov, Edinburgh

By | Acellular / smart materials – 3D architecture, Engineered cell environment, Latest, News, Pluripotent stem cells and engineered cells, Uncategorized

Meeting Focus:
Addressing the Key Translational Challenges of Regenerative Medicine.

Meeting Aim:
To showcase 10 years of UK regenerative medicine translational research and build on the success of UKRMP translational outputs, industrial collaborations and clinical application.

Who Should Attend?
Anyone with an interest in Regenerative Medicine, tools and techniques for cutting edge science and progress from bench to bedside.

Confirmed Speakers:

  • Rawiya Al Hosni, Postdoctoral Researcher, University of Cambridge, UK
  • Ivana Barbaric, Professor, University of Sheffield, UK
  • Roger Barker, Professor, University of Cambridge, UK
  • Jacqueline Barry, Chief Clinical Officer, Cell and Gene Therapy Catapult, UK
  • Catherine Beltran-Rendon, Postdoctoral Researcher, Loughborough University, UK
  • Robin Buckle, Chief Science Officer, Medical Research Council, UK
  • Neil Carragher, Professor, University of Edinburgh, UK
  • Jonathan Dawson, Associate Professor, University of Southampton, UK
  • Charlotte Durkin, Head of Multimodal and Multiscale Biology, Medical Research Council, UK
  • Alicia El Haj, Professor, University of Birmingham, UK
  • Elaine Emmerson, RCUK/UKRI Innovation Fellow & Chancellor’s Fellow, University of Edinburgh, UK
  • Stuart Forbes, Professor, University of Edinburgh, UK
  • Victoria Gadd, Postdoctoral Research Fellow, University of Edinburgh, UK
  • Cedric Ghevaert, Professor, University of Cambridge, UK
  • David Hay, Professor, University of Edinburgh, UK/Founder, Chairman and CEO, Stimuliver, Denmark
  • Zoe Hewitt, Co-Founder and CEO, Regenerative Cell Therapy Consulting Ltd, UK
  • Yuki Ishii, Postdoctoral Researcher, University College London, UK
  • Agnieszka Janeczek, Founder and CEO, Renovos, UK
  • Joanne Jones, Associate Professor, University of Cambridge, UK
  • Janos Kanczler, Lecturer, University of Southampton, UK
  • Owen Laing, PhD Student, University of Sheffield, UK
  • Hannah Levis, Senior Lecturer, University of Liverpool, UK
  • Andrew McCaskie, Professor, University of Cambridge, UK
  • Florian Merkle, Principle Investigator, University of Cambridge, UK
  • Pierre-Alexis Mouthuy, Associate Professor, University of Oxford, UK
  • Marko Nikolic, MRC Clinician Scientist Fellow, University College London, UK
  • Malin Palmer, Professor, Lund University, Sweden
  • Rachael Pearson, Professor, King’s College London, UK
  • Graziella Pellegrini, Professor, University of Modena and Reggio Emilia, Italy
  • Jelle Penders, Co-founder and CEO, SPARTA Biodiscovery Ltd, UK
  • Felicity Rose, Professor, University of Nottingham, UK
  • Kourosh Saeb-Parsy, Professor, University of Cambridge, UK
  • Manuel Salmeron-Sanchez, Professor, University of Glasgow, UK
  • Stefan Schoenfelder, Career Progression Fellow, Babraham Institute, UK
  • Hazel Screen, Professor, Queen Mary University of London, UK
  • Molly Stevens, Professor, University of Oxford and Imperial College London, UK
  • Sarah Waters, Professor, University of Oxford, UK
  • Lisa White, Associate Professor, University of Nottingham, UK
  • Jonathan Wojciechowski, Postdoctoral Research Associate, Imperial College London, UK

Location:
Hosted by the University of Edinburgh at the McEwan Hall, Teviot Place, Edinburgh, EH8 9AG.
On Wed 8 Nov 2023 to Fri 10 Nov 2023.

Networking Opportunities:
Exhibitors Hall – Opening at Registration Wed 8 Nov (Noon) to close on Fri 10 Nov (Noon).
Networking evening at McEwan Hall with hot buffet – Wed 8 Nov.
Gala Dinner at Dynamic Earth – 3 course dinner – Thu 9 Nov.

Registration: 
Details of how to register, deadlines and prices to be confirmed.

Sponsorship Opportunities:
We have a number of Sponsorship opportunities available, if you are interesting in being a sponsor or which to exhibit, please contact Julie Wallace for information.

Connecting Canada and the UK Part 1: Stem Cells and Regenerative Medicine Symposium

By | Acellular / smart materials – 3D architecture, Engineered cell environment, Latest, Pluripotent stem cells and engineered cells

UKRMP and the Canadian Stem Cell Network (SCN) are committed to translating stem cell and regenerative medicine science from the lab to clinical applications. Both organisations are dedicated to training the next generation of regenerative medicine scientists and together are seeking to form an international partnership to enable PhD students, technicians, post-doctoral associates and fellows the opportunity to expand their networks, develop new skills and form collaborations between the two countries.

This symposium is the first in a two parts series aimed at introducing the wealth of research being undertaken in each of the two countries; featuring talks from expert speakers working in the areas of stem cells and regenerative medicine for discovery or in the development/clinical translation of stem cell and regenerative medicine therapies. Register here to attend.

Participants are encouraged to attend to take this opportunity to expand their networks internationally. In Summer 2022, UKRMP and SCN will be hosting Connecting Canada and the UK Part 2: Building Networks; a networking event which will give participants the chance to have one-on-one discussions with colleagues in Canada and the UK.

Speakers:

Who Should Attend?
Investigators working in the field of regenerative medicine and their trainees (i.e., a post-doc, graduate student, research associate, or technician) who are interested in the opportunity to expand their networks, develop new skills and forge new research collaborations between the two countries.

Symposium Learning Objectives:

  • Introduce attendees to research networks in Canada and the UK
  • Profile the high-calibre research in bioengineering and cell and gene therapy for regenerative medicine taking place in both the UK and Canada

Registration Procedure:
This symposium is free to attend for investigators or trainees working on a research project in the field of stem cells and regenerative medicine in a Canadian or UK lab. Online registration is required via this link by Monday, May 23, 2022 at 11:59 PM (sender’s time).

Symposium Location:
Hosted online via Zoom on May 24, 2022 from 4 – 6 P M GMT (11 AM – 1 PM ET).
A link to the online session will be provided following registration.

Registration Deadline: 
Monday, May 23, 2022, 11:59 PM (sender’s time).

 

Canadian Stem Cell Network

Eligibility:
Attendees should be investigators or trainees working on a research project in the field of stem cells and regenerative medicine in a UK or Canadian lab.

Further information:
Please contact one of the UKRMP hub mangers for further information on this symposium or for registration related enquiries:
Robin Morton (ECE): Robin.Morton@ed.ac.uk
Zoe Hewitt (PSEC): z.hewitt@sheffield.ac.uk
Bohwon Kim (Smart Materials): b.kim@imperial.ac.uk

UKRMP to exhibit at the 2021 Till & McCulloch Meeting hosted by the Stem Cell Network, Canada

By | Acellular / smart materials – 3D architecture, Engineered cell environment, Latest, News, Pluripotent stem cells and engineered cells

In our continued efforts to develop strong international partnerships, the UKRMP Hubs will be exhibiting (virtually) at The 2021 Till & McCulloch Meeting (TMM) – hosted by the Canadian Stem Cell Network from November 15 to 17.

Celebrating is 10th year, the Till & McCulloch Meetings are named after Canadian researchers Drs. James Till & Ernest McCulloch, who definitively proved the existence of stem cells in 1961. The TMM is Canada’s largest stem cell research and regenerative medicine conference.  This is a great opportunity to discover what Canada’s leading stem cell scientists, clinicians, bioengineers and ethicists, as well as representatives from industry, government, health and NGO sectors have to offer.

To find out more visit: https://stemcellnetwork.ca or click here.

PSEC welcomes Dr Susanne Sattler to their International Scientific Advisory Board

By | Latest, Pluripotent stem cells and engineered cells, Uncategorized

Dr Susanne Sattler, an independent Research Fellow, and UKRMP alumni , who now leads the cardio-immunology group at the National Heart and Lung Institute at Imperial College London, UK, has agreed to join the PSEC scientific advisory board, following the departure of Professor Paul Fairchild, who recently stood down to focus on his clinical activities.  Dr Sattler has extensive research experience in cardiac immunology and regenerative biology and has contributed a significant body of research on the role of a persistent inflammation-autoimmunity loop in tissue immunopathology hampering regenerative efforts.

The PSEC executive team are thrilled to welcome Susanne to the iSAB and would also like to wish Paul the best of luck, with many thanks for his input over the years.

New Paper: Genetically variant human pluripotent stem cells selectively eliminate wild-type counterparts through YAP-mediated cell competition

By | News, Pluripotent stem cells and engineered cells
Chris Price (PDRA)
Dylan Stavish (PDRA)

As human pluripotent stem cell (hPSC) derived-cell therapies progress into the clinic, one of the challenges we are addressing surrounds the safety of hPSC derivates for use in cellular therapies. A key aspect of this work entails assessing how cells that acquire common chromosomal abnormalities can overtake the existing normal wild-type population.

Researchers (Christopher Price, PhD and Dylan Stavish) from the  Pluripotent Stem Cell and Engineered Cell (PSEC) Hub based at The University of Sheffield, led by Dr Ivana Barbaric, describe in a recent Developmental Cell article, a selection mechanism that facilitates genetically variant cells achieving clonal dominance by eliminating wild-type through YAP mediated cell competition.

https://lnkd.in/dYNDdy8b

By understanding the attributes and culture conditions that encourage genetically variant cells, this work provides a platform for future development and optimization of hPSC culture conditions to safely expand cells for regenerative medicine.

 

Ivana Barbaric (PI Sheffield)

New Paper: Process analysis of pluripotent stem cell differentiation to megakaryocytes to make platelets applying European GMP

By | News, Pluripotent stem cells and engineered cells
Moyra Lawrence (PDRA)

In their new npj Regenerative Medicine paper, PSEC researcher Dr Moyra Lawrence, from the University of Cambridge, in partnership with other researchers from the Cambridge Stem Cell Institute and the Cell and Gene Therapy Catapult, describe the process analysis of megakaryocyte manufacture from iPSCs with a view to manufacturing in vitro platelets to European GMP for transfusion. These general principles will help other cell therapy developers on their translational journey.

Cedric Ghevaert (Deputy Director and PI Cambridge & Deputy Director)

Safety of Stem-Cell Derived Therapies: Trends and Future Technologies 7/8 October 2019

By | Acellular / smart materials – 3D architecture, Engineered cell environment, Pluripotent stem cells and engineered cells

This important meeting, held at the John McIntyre Centre in Edinburgh on 7/8 October 2019, was brought to you by the UK Regenerative Medicine Platform (UKRMP) and the British Pharmacological Society.

Stem cell-derived therapies are complex and diverse, so it is critical that we understand the challenges faced in getting clinical trials for these therapies approved.

Across two days, we discussed how some therapies have made progress towards clinical trials, particularly in relation to assessing safety. We also looked at areas where new technologies can fill vital gaps, such as in combination therapies with smart materials.

The meeting was attended pharmacologists, working in toxicology, clinicians, academics and industry. Regulators, including MHRA and FDA, also joined our panel discussions.

Delegates were able to hear from leaders in the field including Pete Coffey, Agnete Kirkeby, Martin Pera, Kevin Eggan and our key note speaker, Jane Lebkowski.

Find out more